Last update:

Scientists identify promising new target for Alzheimer's-linked brain inflammation

A multidisciplinary team has developed a selective compound that inhibits an enzyme tied to inflammation in people at genetic risk for Alzheimer's, while preserving normal brain function and crossing the blood-brain barrier.

Early treatment can delay rheumatoid arthritis for years

Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with benefits also continuing well after treatment has stopped.

Medical research news

Qatari genetic map reveals over 150,000 structural variants

Research co-led by King's College London and Sidra Medicine, Qatar, has produced the most detailed map to date of large-scale genetic differences in the Qatari population, providing a clearer picture of the genetic diversity ...

Potential new target to treat Parkinson's disease discovered

About 1 million Americans suffer from Parkinson's disease, with around 90,000 new cases diagnosed each year, according to the Parkinson's Foundation. The chronic, degenerative brain disorder destroys dopamine-producing cells ...